IRPresswire

Latest Releases
Login
Menu

Gilead Presents Additional Efficacy, Safety and Demographic Data From PURPOSE 2 Trial at 5th HIV Research for Prevention Conference

NEWS PROVIDED BY

Pharma Stocks Today

October 7, 2024

Pharma Stocks Today

Pharma Stocks Today

email us here

Contact

Pharma Stocks Today

See all from Pharma Stocks Today

email us here

More From This Source

Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025

Biophytis Targets Mobility Restoration in Patients with Obesity

New Simplera Sync™ sensor for the MiniMed™ 780G System now FDA approved

FDA Approves WiSE® System, World’s First and Only Leadless Left Ventricular Endocardial Pacing (LVEP) Device for CRT

Progyny to Host Events Honoring Individuals, Families and Infertility Throughout National Infertility Awareness Week® and Canadian Fertility Awareness Week®

Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets

JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA’s Shift to Non-Animal Testing Methods

Home and Heart of global Toblerone Production: Mondelēz International invests ~65 million Swiss Francs (CHF) in its Toblerone manufacturing facility